Steroid-Adjusted Insulin Plan for Dexamethasone 20 mg
You should increase your total daily insulin significantly—approximately 40-60% or more above your current regimen—with the majority of this increase distributed as fixed bolus doses at breakfast and lunch, plus an increase in your basal insulin, while maintaining close monitoring for the 2-day dexamethasone course. 1
Understanding Dexamethasone's Glycemic Impact
Dexamethasone 20 mg administered at 8 AM causes maximal hyperglycemia at 24 hours after administration, with effects predominantly between midday and midnight 2. The glucose elevation peaks around 4-12 hours post-dose, with blood glucose increases of approximately 0.96-0.97 mmol/L (17-18 mg/dL) at 4-12 hours, returning toward baseline by 48 hours 3, 2. This creates disproportionate daytime hyperglycemia while overnight glucose levels frequently normalize 1.
Your Current Baseline
- Lantus: 22 units daily
- Carb ratio: 1:7 (approximately 9-21 units per meal for 60-150g carbs)
- Current estimated total daily dose: ~50-85 units/day (22 basal + 27-63 bolus)
Recommended Fixed-Dose Steroid Plan
Basal Insulin Adjustment
- Increase Lantus to 30-35 units (approximately 40-60% increase from 22 units) 1
- Continue administering at your usual time
- This addresses fasting hyperglycemia from long-acting dexamethasone 1
Fixed Meal Bolus Doses (NPH Strategy)
Add NPH insulin 20-25 units at 8 AM (given with dexamethasone dose) 1
- NPH peaks at 4-6 hours, matching dexamethasone's hyperglycemic effect 1
- This covers the critical midday-to-evening hyperglycemia window
Breakfast bolus:
- Fixed dose: 15-18 units rapid-acting insulin (for 60-150g carbs, use midpoint of ~100g = 14 units, then add 20-30% = 18 units)
Lunch bolus:
- Fixed dose: 18-21 units rapid-acting insulin (increased 40-50% from baseline calculation due to peak steroid effect)
Dinner bolus:
- Fixed dose: 12-15 units rapid-acting insulin (increased 20-30% from baseline, as steroid effect wanes overnight)
Total Daily Insulin on Steroid Days
- Approximately 95-135 units/day (compared to your baseline 50-85 units)
- This represents the 40-60% increase recommended for high-dose glucocorticoids 1
Critical Implementation Points
Timing Considerations
- Give NPH simultaneously with dexamethasone at 8 AM to match pharmacokinetic profiles 1
- The NPH will peak when dexamethasone causes maximal hyperglycemia (4-12 hours post-dose)
- Overnight, as steroid effects diminish, the shorter-acting NPH will also be wearing off, reducing nocturnal hypoglycemia risk 1
Monitoring Strategy
- Check blood glucose before each meal and at bedtime
- Add a 2-3 AM check on the first night to ensure no nocturnal hypoglycemia
- Use your existing ISF (1:25) for correctional doses above target, but expect to need corrections frequently
Day-by-Day Adjustments
Day 1 (first dexamethasone dose):
- Implement full plan as outlined above
- Expect glucose to rise progressively through the day
Day 2 (second dexamethasone dose):
- Continue same regimen
- May need additional 10-20% increase in bolus doses if Day 1 showed persistent hyperglycemia >250 mg/dL 1
Day 3 (no dexamethasone):
- Reduce NPH to 10-12 units or discontinue
- Reduce meal boluses by 30-40% back toward baseline
- Return Lantus to 25-28 units
Day 4 onwards:
- Return to baseline regimen (22 units Lantus, standard carb ratios)
- Monitor for residual hyperglycemia, which should resolve by 48 hours post-last dose 2
Safety Considerations
Hypoglycemia Risk
The basal-bolus approach carries 4-6 times higher hypoglycemia risk than sliding scale alone, but provides superior glycemic control and reduces complications 4. The fixed-dose approach with NPH specifically addresses the steroid's temporal pattern, minimizing overnight hypoglycemia risk that would occur with long-acting basal insulin alone 1.
When to Seek Help
- Blood glucose consistently >300 mg/dL despite corrections
- Any blood glucose <70 mg/dL
- Symptoms of DKA (nausea, vomiting, abdominal pain, confusion)
Common Pitfall to Avoid
Do not rely on sliding scale insulin alone for steroid-induced hyperglycemia—this approach is associated with poor glycemic control and increased risk of DKA 4, 5. The evidence clearly shows that basal-bolus regimens with NPH are superior for managing dexamethasone-induced hyperglycemia, achieving mean glucose reductions of 52 mg/dL versus increases of 128 mg/dL with sliding scale alone 5.
Why This Approach Works
Research specifically in patients receiving dexamethasone demonstrates that basal-bolus insulin regimens achieve average blood glucose of 219 mg/dL versus 301 mg/dL with sliding scale, with insulin requirements of approximately 122 units/day in the basal-bolus group 5. The NPH component is critical because glargine-based regimens may undertreat daytime hyperglycemia while causing nocturnal hypoglycemia due to the mismatch with dexamethasone's temporal effects 1, 6.